Received Sep 23, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| HEPAB | HEP A + HEP B (TWINRIX) | GLAXOSMITHKLINE BIOLOGICALS | 2 | UNK | — |
Late 2dn and 3rd dose; This non-serious case was reported by a pharmacist via call center representative and described the occurrence of incomplete course of vaccination in a 44-year-old female patient who received HAB (Twinrix) for prophylaxis. Previously administered products included Twinrix (1st dose received in October 2017). The patient did not receive the 2nd dose of Twinrix. The patient experienced incomplete course of vaccination (Verbatim: Late 2dn and 3rd dose). The outcome of the incomplete course of vaccination was not applicable. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional Information: GSK Receipt date: 17-SEP-2025 The reporter contacted us regarding a patient who had received the first dose of the Twinrix vaccine a couple of years ago. The reporter wanted to confirm whether the patient only needed to receive the second and third doses to complete the vaccination schedule. During the call, the healthcare professional (HCP) did not provide any specific patient information. They only mentioned that the patient had received the first dose of Twinrix. The HCP stated that the first dose was administered in October 2017 but did not specify the exact date. For documentation purposes, we recorded the date as 01-OCT-2017, as the system format does not allow the date field to be left blank